Vertak Pharma And Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Months 12 Days
About Vertak Pharma And Research
Vertak Pharma And Research Private Limited (VPARPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 October 2024 ( three months 12 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Roshni and Krishan Tak serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47721RJ2024PTC098038
-
Company No.
098038
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Oct 2024
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Who are the key members and board of directors at Vertak Pharma And Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roshni
|
Director | 29-Oct-2024 | Current |
|
Krishan Tak
|
Director | 29-Oct-2024 | Current |
Financial Performance of Vertak Pharma And Research.
Enhance accessibility to Vertak Pharma And Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vertak Pharma And Research?
Unlock access to Vertak Pharma And Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vertak Security Services LlpRoshni and Krishan Tak are mutual person
-
Orfa Farmer Producer Company Limited
Roshni and Krishan Tak are mutual person
-
Vertak Wines & Spirits Private Limited
Roshni and Krishan Tak are mutual person
-
Super Fine Mines And Minerals Private Limited
Roshni and Krishan Tak are mutual person
-
Vertak Green Energy Private Limited
Roshni and Krishan Tak are mutual person
-
Amritdhara Water Projects Limited
Roshni and Krishan Tak are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vertak Pharma And Research?
Unlock and access historical data on people associated with Vertak Pharma And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vertak Pharma And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vertak Pharma And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.